J030-0405 Screening compound: 1-[11-oxo-2-(piperidinosulfonyl)-10,11-dihydrodibenzo[b,f][1,4]oxazepin-3-yl]-4-piperidinecarboxamide

J030-0405 Screening compound: 1-[11-oxo-2-(piperidinosulfonyl)-10,11-dihydrodibenzo[b,f][1,4]oxazepin-3-yl]-4-piperidinecarboxamide
J030-0405 Screening compound: 1-[11-oxo-2-(piperidinosulfonyl)-10,11-dihydrodibenzo[b,f][1,4]oxazepin-3-yl]-4-piperidinecarboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound J030-0405
1-[11-oxo-2-(piperidinosulfonyl)-10,11-dihydrodibenzo[b,f][1,4]oxazepin-3-yl]-4-piperidinecarboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

J030-0405

Molecular Formula

C24H28N4O5S (C24 H28 N4 O5 S)

Compound Name

1-[11-oxo-2-(piperidinosulfonyl)-10,11-dihydrodibenzo[b,f][1,4]oxazepin-3-yl]-4-piperidinecarboxamide

IUPAC name

1-[10-oxo-13-(piperidine-1-sulfonyl)-2-oxa-9-azatricyclo[9.4.0.0^{38}]pentadeca-1(15)3571113-hexaen-14-yl]piperidine-4-carboxamide

SMILES

NC(C(CC1)CCN1c(cc(c1c2)Oc(cccc3)c3NC1=O)c2S(N1CCCCC1)(=O)=O)=O

InChI

InChI=1S/C24H28N4O5S/c25-23(29)16-8-12-27(13-9-16)19-15-21-17(24(30)26-18-6-2-3-7-20(18)33-21)14-22(19)34(31,32)28-10-4-1-5-11-28/h2-3,6-7,14-16H,1,4-5,8-13H2,(H2,25,29)(H,26,30)

InChI Key

DIYZLAJUUSTJHE-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27220200

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

484.58

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

3.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

2.813

Distribution Coefficient, logD

2.744

Water Solubility, LogSw

-3.72

Polar Surface Area

101.261

Acid Dissociation Constant (pKa)

8.17

Base Dissociation Constant (pKb)

4.74

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

41.70

J030-0405 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Antiviral HBV Library (10007 compounds)

Antiviral Library (67538 compounds)

KRAS-Targeted Library (16000 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

Nucleic Acid Ligands (8311 compounds)

Protein-Protein Interaction Library (218420 compounds)

Recognition Elements PPI Library (24135 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Hemic and lymphatic
  • Cardiovascular
  • Infections
  • Cancer
  • Musculoskeletal
  • Nervous system
  • Hemic and lymphatic
  • Immune system
Targets:
  • Kinases
  • Kinases
Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics

References: we are preparing a list of scientific research reports with J030-0405 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound J030-0405?
Check Price and Availability of J030-0405, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of J030-0405 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for J030-0405
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for J030-0405
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of J030-0405 available by request